The global single-cell omics market has witnessed significant growth over the past few years owing to rising technological advancements in single-cell analysis techniques. Single-cell omics enables examination of biological systems at single-cell resolution through measurement of various –omics data from individual cells. This helps in understanding heterogeneity within cell populations and developmental processes at single-cell level. Common techniques used in single-cell omics include single-cell genomics, epigenomics, transcriptomics, proteomics and metabolomics. Single-cell omics finds wide application in research areas such as cancer immunotherapy, stem cell research, neurobiology, immunology and microbiology.
The Global Single-cell Omics Market is estimated to be valued at US$ 1.63 BN in 2024 and is expected to exhibit a CAGR of 16.% over the forecast period 2024 to 2031.
Key Takeaways
Key players operating in The Global Single-Cell Omics Market are Bio-Rad Laboratories Inc., Agilent Technologies Inc., QIAGEN N.V., Thermo Fisher Scientific, Illumina Inc., Roche, Bio-Techne, and Pacific Biosciences. Bio-Rad Laboratories Inc. and 10x Genomics are widely recognized as leaders in the single-cell analysis market.
The global single-cell omics market is anticipated to witness robust growth over the forecast period. This is attributed to growing demand for understanding heterogeneity at single-cell level from research institutes and pharma companies. Single-cell omics is helping enable discoveries in disease research, immunotherapy, and regenerative medicine.
Major players in the single-cell omics market are focusing on global expansion through collaborations and partnerships to strengthen their geographical presence. Companies are also making significant investments in R&D to develop novel single-cell analysis platforms, kits and reagents with advanced capabilities. This is expected to boost the market growth during the forecast period.
Market Drivers
Technological advancements is a major market driver. Continuous innovation is aiding development of high-throughput single-cell analysis platforms that enable multi-omics profiling of thousands of cells within a short period. For instance, massively parallel single-cell sequencing platforms can profile gene expression in over 10,000 cells simultaneously. Additionally, miniaturization of techniques is making single-cell analysis more affordable and accessible to small labs. These advances are supporting widespread adoption of single-cell omics methods.
Impact of geopolitical situation on the growth of Global Single-cell Omics Market
The global single-cell omics market is witnessing rapid transformations owing to several geopolitical factors. The ongoing geopolitical tensions and conflicts between major economies like the US, China and Russia have disrupted global supply chains and production networks. This has negatively impacted the availability of crucial raw materials and components used in omics technologies. Moreover, restrictions on trade and technology transfers between these nations have paused collaborations in omics research. The market players now need to diversify their manufacturing and sourcing strategies and establish localized production facilities to minimize supply risks.
The pandemic recovery has also been uneven across different regions due to heterogeneity in epidemiological conditions, vaccination rates, and economic recovery measures. This has dampened research activities and delayed new product launches in certain parts of the world. To counter these challenges, companies must focus on pandemic-resilient business models, prioritize markets showing strong recovery, and facilitate technology transfers and knowledge-sharing among collaborators in developing nations. Overall, careful monitoring of geopolitical shifts and adapting short-term and long-term strategies accordingly will be critical for sustaining growth in this dynamic market landscape.
Geographical regions with high concentration of Global Single-cell Omics Market value
North America dominates the global single-cell omics market currently, accounting for over 40% of the total market value. This is attributed to presence of major players and robust research infrastructure in the US. The region continues to invest heavily inmulti-omics technologies and single-cell analysis. Asia Pacific is emerging as a high growth market with China and Japan among the top spenders. Increasing government research funding and growing biotechnology industry in countries like China, South Korea and India provides huge opportunities. Europe is another major regional market led by Western European countries like Germany, UK and France.
Fastest growing region in the Global Single-cell Omics Market
Asia Pacific region is poised to register the highest growth in the global single-cell omics market during the forecast period. This is due to rising healthcare expenditure, growing biopharmaceutical industry, and significant initiatives by governments to enhance life sciences research and build world-class research institutes. Countries like China and India offer low-cost and high-quality manufacturing capabilities attracting global market leaders to establish R&D and production hubs. Rising scientific talent pool and increasing collaborations with developed markets will further support market expansion. With strongest growth anticipated across APAC economics, companies must devise regional market access strategies to leverage untapped opportunities.
Get More Insights On Global Single-Cell Omics Market
TheBusinessResearchCompany published its Genomics Global Market Report 2020 which provides strategists, marketers and senior management with the critical information they need to assess the global genomics market.
The report covers the genomics market’s segments- by product type: instrument (including systems, service contract and software); reagents (including reagents and consumables), by process: cell isolation; sample preparation; genomic analysis, and by end user: academic institutes; biopharmaceutical companies; clinical research institutes.Explore Complete Report https://www.thebusinessresearchcompany.com/report/genomics-market-global-report-2020-covid-19-implications-and-growthGenomics Global Market Report 2020 is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 60 geographies.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by region and by country.
It also compares the market’s historic and forecast growth.
It covers all the regions, key developed countries and major emerging markets.
The major regions included in the report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.Companies are investing in new product launches to increase their revenue and expand their consumer base, as well as for gaining a competitive edge over their rivals.
